Answers are grounded in this paper and cite their sources.
Therapeutic regimens involving the transfusion of blood components are a matter of debate, not only with regard to patients' safety, but also with regard to cost-effectiveness. The following different measures to reduce the use of blood components and their efficacy are discussed: autologous transfusion, including predonation, isovolaemic haemodilution and peri-operative retransfusion; toleration of a lower haematocrit; and measures to reduce blood loss. In particular, a combination of these methods may be most effective at reducing transfusion needs.
No takes yet. Share an insight, caveat, or question.
Mertes et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: